732 related articles for article (PubMed ID: 30473057)
1. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.
Ahmad A; Ali T; Kim MW; Khan A; Jo MH; Rehman SU; Khan MS; Abid NB; Khan M; Ullah R; Jo MG; Kim MO
Metabolism; 2019 Jan; 90():31-43. PubMed ID: 30473057
[TBL] [Abstract][Full Text] [Related]
2. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
Luo L; Fang K; Dan X; Gu M
Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
[TBL] [Abstract][Full Text] [Related]
3. San-Huang-Tang protects obesity/diabetes induced NAFLD by upregulating PGC-1α/PEPCK signaling in obese and galr1 knockout mice models.
Fang P; Sun Y; Gu X; Han L; Han S; Shang Y; Luan Z; Lu N; Ge R; Shi M; Zhang Z; Min W
J Ethnopharmacol; 2020 Mar; 250():112483. PubMed ID: 31843573
[TBL] [Abstract][Full Text] [Related]
4. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
Li Q; Tan JX; He Y; Bai F; Li SW; Hou YW; Ji LS; Gao YT; Zhang X; Zhou ZH; Yu Z; Fang M; Gao YQ; Li M
Int J Biol Sci; 2022; 18(4):1594-1611. PubMed ID: 35280674
[No Abstract] [Full Text] [Related]
5. Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits.
Shah SA; Yoon GH; Chung SS; Abid MN; Kim TH; Lee HY; Kim MO
Mol Psychiatry; 2017 Mar; 22(3):407-416. PubMed ID: 27001618
[TBL] [Abstract][Full Text] [Related]
6. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
7. Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.
Ma C; Wang Z; Xia R; Wei L; Zhang C; Zhang J; Zhao L; Wu H; Kang L; Yang S
Biomed Pharmacother; 2021 May; 137():111344. PubMed ID: 33581653
[TBL] [Abstract][Full Text] [Related]
8. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis.
Handa P; Maliken BD; Nelson JE; Morgan-Stevenson V; Messner DJ; Dhillon BK; Klintworth HM; Beauchamp M; Yeh MM; Elfers CT; Roth CL; Kowdley KV
Hepatology; 2014 Jul; 60(1):133-45. PubMed ID: 24464605
[TBL] [Abstract][Full Text] [Related]
9. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
10. The Adiponectin Homolog Osmotin Enhances Neurite Outgrowth and Synaptic Complexity via AdipoR1/NgR1 Signaling in Alzheimer's Disease.
Yoon G; Shah SA; Ali T; Kim MO
Mol Neurobiol; 2018 Aug; 55(8):6673-6686. PubMed ID: 29335844
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice.
Zheng Y; Liu T; Wang Z; Xu Y; Zhang Q; Luo D
Int J Biol Macromol; 2018 Jun; 112():929-936. PubMed ID: 29447962
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.
Yamauchi T; Nio Y; Maki T; Kobayashi M; Takazawa T; Iwabu M; Okada-Iwabu M; Kawamoto S; Kubota N; Kubota T; Ito Y; Kamon J; Tsuchida A; Kumagai K; Kozono H; Hada Y; Ogata H; Tokuyama K; Tsunoda M; Ide T; Murakami K; Awazawa M; Takamoto I; Froguel P; Hara K; Tobe K; Nagai R; Ueki K; Kadowaki T
Nat Med; 2007 Mar; 13(3):332-9. PubMed ID: 17268472
[TBL] [Abstract][Full Text] [Related]
13. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease.
Ali T; Rehman SU; Khan A; Badshah H; Abid NB; Kim MW; Jo MH; Chung SS; Lee HG; Rutten BPF; Kim MO
Mol Neurodegener; 2021 Apr; 16(1):23. PubMed ID: 33849621
[TBL] [Abstract][Full Text] [Related]
15. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Mycobacterium Bovis Bacillus Calmette-Guérin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice.
Inafuku M; Matsuzaki G; Oku H
PLoS One; 2015; 10(6):e0128676. PubMed ID: 26039731
[TBL] [Abstract][Full Text] [Related]
17. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
18. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice.
Goto T; Teraminami A; Lee JY; Ohyama K; Funakoshi K; Kim YI; Hirai S; Uemura T; Yu R; Takahashi N; Kawada T
J Nutr Biochem; 2012 Jul; 23(7):768-76. PubMed ID: 21889885
[TBL] [Abstract][Full Text] [Related]
19. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
20. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells.
Xin XM; Zhong MX; Yang GL; Peng Y; Zhang YL; Zhu W
World J Gastroenterol; 2014 Nov; 20(42):15727-35. PubMed ID: 25400456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
